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Implication for health policy/practice/research/medical education: {#key1}
==================================================================

Diabetic dialysis patients tend to have a complex oral status and special attention should be given to their oral health.

Introduction {#s1}
============

Diabetes is a common disease affecting more than 387 million people worldwide ([@R1]). The condition is associated with many complications and among them, diabetic nephropathy is one of the major complications that develops in 40% of patients with insulin dependent diabetes mellitus (DM) ([@R2]). The high prevalence of DM results in a sustained increase in the prevalence of diabetic nephropathy, which in return, causes increased kidney failure ([@R3]). Patients with DM are faced with more oral disorders than the normal population. Caries and periodontal disease are a well-documented complication of diabetes. Other complications include xerostomia, bacterial, viral and fungal infections and poor wound healing ([@R4],[@R5]).

On the other hand, chronic renal failure is seen with several oral changes such as ammonia-like smell, dysgeusia, stomatitis, gingivitis, decreased salivary flow and parotitis ([@R6]). Although caries is not a characteristic of disease some oral lesions like lichen planus, hairy tongue and pyogenic granuloma have been reported with a higher rate in these patients ([@R7]).

The oral cavity is colonized with different species of bacteria and some of these bacteria contribute to some of the most common bacterial infections such as caries and periodontitis ([@R8]). The most important causes of dental caries are *Lactobacillus and Streptococcus mutans* ([@R9]).

Patients with diabetes are documented to have higher levels of dental caries due to multiple factors, on the other hand some studies have shown that patients with chronic renal failure may have lower levels of cariogenic bacteria in their oral cavity ([@R4],[@R10]).

Different results regarding the oral microflora in patients with diabetes and renal failure have been reported ([@R11]-[@R13]). Ahmadieh et al ([@R12]) reported that hemodialysis and kidney transplantation could affect the oral microflora. They found that oral *Streptococcus mutans* and *Lactobacilli* were seen less frequently after kidney transplantation. In another study, the oral health of patients on hemodialysis for diabetic nephropathy and chronic glomerulonephritis was studied and they found that fewer teeth and a worse periodontal health was seen in diabetic nephropathy patients compared to other groups ([@R4]).

Objectives {#s2}
==========

Due to the discrepancy in the prevalence of dental caries among these patients, in this study we compared oral *Lactobacillus and Streptococcus mutans* among patients with end-stage renal disease and diabetic nephropathy, both undergoing dialysis with the normal population.

Patients and Methods {#s3}
====================

Study settings and patients {#s3-0-1}
---------------------------

This study was conducted in Faghihi hospital, Shiraz, Iran. The study population was selected from patients that were referred to our medical care center for dialysis, during November 2014 to January 2014. Patients who received periodontal treatment during the past year, brushed their teeth or ate something within one hour prior to sampling, took antibiotics or used mouth wash in the past previous month, were seropositive or suspicious to have HIV, hepatitis B or C, chronic smokers and patients that had any other systemic disease that could have affected the oral microflora were excluded from the study. They were then divided into two groups: group 1 or the diabetic dialysis patients, group 2 or the non-diabetic dialysis patients. A third group was selected from the healthy people who were accompanying the patients during the dialysis, as the control group.

Sample collection {#s3-0-2}
-----------------

Oral saliva samples were collected from each patient using a swab. The swab was rotated to remove saliva from the dorsum of the tongue and the floor of the mouth. It was then immediately placed into a sterile bottle containing 1 mL of thioglycolate medium (HiMedia; India) in order to maintain the viability of the microorganisms collected. Within 15 minutes of collection, the swabs were transported to the microbiology laboratory for the microbiological testing.

For the enumeration of *Streptococcus mutans*, mitis salivarius agar (HiMedia, Indian) was used. The agar was supplemented with 0.1% potassium tellurite, bacitracin 0.2 U/mL, and sucrose 15% w/v (MSA). The samples were then diluted by 100 folds with salin, after which 10 µL of the diluted samples were transferred to the colony plates. The plates were then set in microaerophilic conditions and incubated for 1 day at 37°C.

For the *Lactobacillus*, Rogosa agar (HiMedia, India) was employed. For the enumeration of the bacteria, 20 µL of the samples was transported to the plates. The inoculated plates were then incubated in an anaerobic jar with an anaerobic atmosphere of 85% nitrogen, 5%-10% carbon dioxide and 5%-10% oxygen for 4 days at 37°C.

Assessment of the cultures and lab tests were all performed by a single microbiologist who was blinded to the study groups.

Classification and evaluation {#s3-0-3}
-----------------------------

The salivary levels of the *S. mutans* were classified into five groups based on the colony count: 1: 0--10^5^ CFU/mL of saliva, 2: 10^5^-5×10^5^ CFU/mL, 3: 5×10^5^-10^6^ CFU/mL, 4: 10^6^ -1.5×10^6^ and 5: \>1.5×10^6^.

The *Lactobacillus* were classified into six groups based on the colony count in each sample; 1: Non-detectable, 2: 1--10^3^ CFU/mL saliva, 3: 10^3^ --5×10^3^ CFU/mL, 4: 5×10^3^-10^4^ CFU/mL saliva, 5: 10^4^ -1.5×10^4^ CFU/mL and 6: \>1.5×10^4^.

Patients' information regarding age, sex, fasting blood sugar (FBS) levels, creatinine and blood urea nitrogen (BUN) levels prior to dialysis and after dialysis (only for the case groups) were recorded and compared between the groups.

Ethical issues {#s3-0-4}
--------------

The study protocol was in accordance with the declaration of Helsinki and was approved by the Ethics Committee of Shiraz University of Medical Sciences. All participants gave their informed written consent to enter the study (Ethical code\# 2232).

Statistical analysis {#s3-0-5}
--------------------

The statistical analysis was done using the SPSS^®^ for windows^®^, version 17 (SPSS Inc., Chicago, IL, USA). The data are displayed and compared as frequency, percent, median and interquartile range. The Kruskal-Wallis test was used to compare means among the 3 groups and the chi-square test was used for comparison of means between 2 groups. The Spearman's correlation was used to assess the relationship between the frequency of each bacteria and different parameters including age, FBS, creatinine and BUN levels in the groups. A two-tailed *P* value of less than 0.05 was considered as statistically significant.

Result {#s4}
======

Baseline characteristics {#s4-0-1}
------------------------

Eighty-five people entered the study and were evaluated. Group 1 (diabetic dialysis patients) included 30 patients, group 2 (non-diabetic dialysis patients) included 28 patients and group 3 (control group) included 27 healthy people. The patients did not display any significant difference regarding age and sex. The baseline characteristic of the participants is displayed in [Table 1](#T1){ref-type="table"}.

###### Baseline characteristics and frequency of bacteria in the three groups^a^

  ---------------------------------------------------------------- -------------------- -------------------- -------------------- -------------------
  **Variables**                                                    **Group 1 (n=30)**   **Group 2 (n=28)**   **Group 3 (n=27)**   ***P*** **value**
  Age (years)                                                      65 ± 11              59 ± 14              63 ± 12              0.119
  Sex (m : f)                                                      20 : 10              17 : 11              17 : 10              0.893
  FBS                                                              194 ± 76             94 ± 19              --                   \<0.001
  Creatinine before dialysis                                       6.5 ± 1.5            7.9 ± 2.3            --                   0.008
  Creatinine after dialysis                                        3.1 ± 0.8            3.5 ± 1.1            --                   0.07
  BUN before dialysis                                              54 ± 11              59 ± 17              --                   0.26
  BUN after dialysis                                               19 ± 5               19 ± 5               --                   0.91
  *Streptococcus mutans (*Frequency based on grouping^b^), n (%)                                             0.092                
  Group 1                                                          2 (6.7)              4 (14.3)             1 (3.7)              
  Group 2                                                          7 (23.3)             10 (35.7)            7 (25.9)             
  Group 3                                                          7 (23.3)             5 (17.9)             1 (3.7)              
  Group 4                                                          3 (10)               1 (3.6)              4 (14.8)             
  Group 5                                                          11(36.7)             8 (28.6)             14 (51.9)            
  *Lactobacillus (*Frequency based on grouping^c^), n (%)                                                    0.966                
  Group 1                                                          17 (56.7)            14 (50)              13 (48.1)            
  Group 2                                                          4 (13.3)             8 (28.6)             5 (18.5)             
  Group 3                                                          4 (13.3)             2 (7.1)              7 (25.9)             
  Group 4                                                          0 (0)                1 (3.6)              2 (7.4)              
  Group 5                                                          2 (6.7)              0 (0)                0 (0)                
  Group 6                                                          3 (10)               3 (10.7)             0 (0)                
  ---------------------------------------------------------------- -------------------- -------------------- -------------------- -------------------

^a^Group 1 includes the diabetic dialysis patients; group 2 includes the non-diabetic dialysis patients; group 3 includes the control group.

^b^ The *S. mutans* were divided into 5 groups based on their frequency in each group: group 1: 0-10^5^; group 2: 10^5^- 5×10^5^; group 3: 5×10^5^ -- 10^6^; group 4: 10^6^ -- 1.5 × 10^6^; group 5: \> 1.5 × 10^6^.

Comparison of groups and correlations {#s4-0-2}
-------------------------------------

For comparison of the oral flora between the three groups, each of the two types of bacteria was classified into 5 groups as mentioned before. The results did not show a statistically significant difference in the amount of bacteria between the three groups (*P*=0.092 and *P*=0.966 for *S. mutans* and *lactobacillus*, respectively) ([Table 1](#T1){ref-type="table"}).

A statistically significant and positive correlation was seen between FBS and the amount of *S. mutans* in group 1, in other words an increase in the FBS of the diabetic dialysis patients resulted in an increase in the amount of oral *S. mutans* (*P*=0.023; r=0.413), although this correlation was not found with *Lactobacillus* for this group (*P*=0.129; r=0283).

In the non-diabetic dialysis group a meaningful and positive correlation was found between the level of BUN after dialysis and the amount of oral *S. mutans* (*P*=0.03; r=0.403), although this correlation was not seen between BUN before dialysis and *S. mutans* for this group of patients (*P*=0.29; r=0.205).

None of the other parameters showed a significant correlation with either of the bacteria (*P*\>0.05; [Table 2](#T2){ref-type="table"}).

###### Correlation coefficient between *Streptococcus mutans* and *Lactobacillus* frequency with differed variables in the three groups^a^

  ---------------------------- ---------------------- ---------------------- ---------------------- ------------ ------------- ------------ ------------- ------------- ------------- ------------ ------------- -------
  **Variables**                **Group 1 (n = 30)**   **Group 2 (n = 28)**   **Group 3 (n = 27)**                                                                                                                
  **SM (r)**                   **P value**            **LB (r)**             **P value**            **SM.(r)**   **P value**   **LB (r)**   **P value**   **SM. (r)**   **P value**   **LB (r)**   **P value**   
  FBS                          0.413                  0.023                  0.283                  0.12         0.151         0.44         -0.234        0.23          \-            \-           \-            \-
  Creatinine before dialysis   0.16                   0.398                  0.098                  0.60         -0.66         0.74         -0.053        0.79          \-            \-           \-            \-
  Creatinine after dialysis    -0.088                 0.643                  0.151                  0.42         -0.64         0.74         0.152         0.44          \-            \-           \-            \-
  BUN before dialysis          -0.025                 0.894                  0.22                   0.24         0.205         0.29         -0.095        0.63          \-            \-           \-            \-
  BUN after dialysis           -0.173                 0.361                  -0.25                  0.17         0.403         0.03         0             0.99          \-            \-           \-            \-
  Age                          0.041                  0.828                  -0.258                 0.168        0.396         0.037        -0.041        0.637         -0.054        0.78         -0.422        0.029
  ---------------------------- ---------------------- ---------------------- ---------------------- ------------ ------------- ------------ ------------- ------------- ------------- ------------ ------------- -------

Abbreviations: FBS, fasting blood sugar; BUN, blood urea nitrogen; SM, *Streptococcus mutans*; LB, *Lactobacillus.*

^a^Group 1 includes the diabetic dialysis patients; group 2 includes the non-diabetic dialysis patients; group 3 includes the control group.

Discussion {#s5}
==========

In our study we documented a positive correlation between the amount of FBS and the amount of oral *S. mutans* in the diabetic patients, furthermore the BUN after dialysis was positively correlated with the amount of oral *S. mutans* in the non-diabetic dialysis patients. No meaningful correlation between *Lactobacillus* and any of the disease related variables that we assessed in our study was seen.

In a recent study by Teratani et al ([@R4]) in 2013, the oral health was compared between patients with diabetic nephropathy (DN) and chronic glomerulonephritis (CGN) with a control group. They found that patients with diabetic nephropathy had overall worse oral health in compared to both CGN patients and the control group. Although both the CGN and the DN group both had a worse condition regarding salivary flow rate and total xerostomia score. The xerostomia score was worse in patients with DN compared to the CGN group. In another study in 2011 ([@R14]), comparing oral health among patients with DN and patients with other causes of chronic kidney disease (CKD) at pre-dialysis stage, they found that DN patients had higher rates of dental caries. Our study also showed a positive correlation between the amount of *S. mutans* and FBS in the diabetic patients, furthermore the rate of cariogenic bacteria did show a meaningful difference between the three groups. This could have been due to multiple reasons including that caries might not only be dependent on oral microflora and other factors such as salivary flow rates and the amount of sugar in the saliva could have affected the results, furthermore patients with renal failure tend to have higher pH of the oral cavity due to their uremic state which could have provided protection against dental caries ([@R10]).

In one study in 2010 ([@R12]), a higher rate of *S. mutans* was seen in the control group compared to patients with hemodialysis and renal transplant and a lower rate of lactobacilli was seen in the control group, although these differences were not significantly meaningful. This result was similar to our findings. This was further supported by other studies that found a lower rate of dental caries in end stage renal failure and renal transplant patients ([@R15],[@R16]).

In one review by Soell et al in 2007 ([@R17]), they concluded that diabetic patients have an overall worse oral health in wise of dental caries when compared to healthy individuals. They concluded that this is due to two factors of increased oral sugar levels and increased *S. mutans* and by controlling these two factors oral caries becomes the same as in healthy individuals.

Similar to the previous study, one study in 2013 ([@R18]), evaluated the dental caries of diabetic (controlled and uncontrolled) and non-diabetic patients. They found that the diabetic group had the highest amount of oral *S. mutans* and lactobacilli in comparison to the other groups (*P*\<0.001). They also found that the amount of caries in the uncontrolled diabetic group correlated positively with the amount of HbA1c (r=0.574 and *P*=0.003), which is consistent with our findings regarding the correlations between the amount of *S. mutans* and FBS in our diabetic nephropathy group (r=0.413 and *P*=0.023). Diabetic patients are documented to be at higher risks of developing conditions like periodontitis and xerostomia apart from the added nephropathy which acts as a separate risk factor for poor hygiene ([@R19],[@R20]). As shown in the previously mentioned studies patients with diabetes have lower salivary flow rates, which put them at higher risks of caries. Similar result was also seen in other studies evaluating the cariogenic bacteria in diabetic patients ([@R21]).

The findings in our study suggest that the BUN after dialysis may reflect the oral health status, so further studies should be conducted to evaluate if BUN after dialysis could be used as an indicator of caries for non-diabetic dialysis patients. We also found that the higher blood sugar in diabetic patients reflects a worse oral health and this shows that the less the diabetes is controlled the more oral caries is expected in this group of patients. We found that the non-diabetic patients had a lower amount of cariogenic bacteria than the control group. In the diabetic dialysis patients, considering their diabetes, we expected a worse oral health as indicated by some of the previously mentioned studies ([@R4],[@R12],[@R17]), on the other hand considering their renal failure we expected less oral caries. In our study we found no difference in the amount of cariogenic bacteria in these patients compared to the other groups showing that these patients are complicated regarding their oral health status and special attention should be given to these patients' dental health.

Larger scale studies considering different types of renal failure, patients with concomitant diabetes and in patients with different socio-economic status should be conducted to further compare the difference in the oral health of these patients.

Conclusion {#s6}
==========

Despite the differences in the prevalence of caries that have been reported between renal failure patients and diabetic patients, we did not find any significant difference between diabetic dialysis and non-diabetic dialysis patients, regarding their amount of oral cariogenic bacteria. In renal failure patients the BUN level after dialysis was positively correlated with their amount of *S. mutans*, furthermore diabetic patients displayed more *S. mutans* by an increase in their FBS.

Limitations of the study {#s7}
========================

Our study had some limitations. First the types of medications that the patients were using were not taken into consideration. This may have had adverse effects on their oral health and might have affected the results of our study. Another factor that might have affected the oral caries was the socio-economic status as indicated by one study ([@R22]). It was not taken into consideration as a factor in our study, although most of our recruited patients had a poor socio-economic status.
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